DISSOCIATION BETWEEN THE ATTENTIONAL EFFECTS OF INFUSIONS OF A BENZODIAZEPINE RECEPTOR AGONIST AND AN INVERSE AGONIST INTO THE BASAL FOREBRAIN

The effects of infusions of the benzodiazepine receptor (BZR) full ago nist chlordiazepoxide (CDP) or the full inverse agonist beta-CCM into the basal forebrain on behavioral vigilance were tested. Vigilance was measured by using a previously characterized task that requires the a nimals to discriminate between visual signals of variable length and n on-signal events. Measures of performance,included hits, misses, corre ct rejections, false alarms, side bias, and errors of omission. Follow ing the infusion of saline (0.5 mu l/hemisphere), the relative number of hits varied with signal length. In response to shorter signals, the number of hits decreased over time, indicating a vigilance decrement. Infusions of CDP (20, 40 mu g/hemisphere) initially decreased the rel ative number of hits in response to shorter signals and, later in the course of the test sessions, to longer signals as well. CDP did not af fect the relative number of correct rejections. In contrast, infusions of the inverse agonist beta-CCM (1.5, 3.0 mu g/hemisphere) did not af fect the relative number of hits but decreased the relative number of correct rejections (i.e., increased the number of false alarms). These data suggest that the basal forebrain mediates the attentional effect s of BZR ligands. As systemic or intrabasalis administration of BZR ag onists and inverse agonists was previously demonstrated to decrease an d augment, respectively, activated cortical acetylcholine (ACh) efflux , their effects on behavioral vigilance are hypothesized to be mediate d via their effects on cortical ACh.